Donate For Public and Patients Store Search

F014 - Multidisciplinary Management of Chronic GVHD

Friday, March 1; 9:00 AM - 11:00 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify the variable skin and mucosal manifestation of GVHD
  • Recognize the skin and mucosal manifestations that are most likely to lead to severe sequelae/damage and require aggressive therapy
  • Treat skin manifestations using a multi-modality approach with topical and systemic therapies as well as supportive care measures

Description

GVHD is a multisystem disease with protean skin manifestations as well as frequent involvement of the oral, ocular and genital mucosae. This session will utilize Dermatology and non-Dermatology sub-specialists in the NIH GVHD multidisciplinary program to provide a framework for coordinated management of GVHD focusing on skin and mucosal manifestations. This will include a comprehensive approach to care, including topical and systemic therapy, adaptive tools and rehabilitation measures.

Disclosures

  • Bishop, Rachel, MD, MPH: no financial relationships exist with commercial interests.
  • Comis, Leora, MPA: no financial relationships exist with commercial interests.
  • Cowen, Edward W., MD: Elsevier Inc. – O(OB); UpToDate, Inc – O(OB);
  • Mays, Jacqueline: no financial relationships exist with commercial interests.
  • Naik, Haley, MD: AbbVie – I(Grants/Research Funding);
  • Rosenstein, Rachel, MD, PhD: Aclaris Therapeutics Inc. – SH(ST);
Schedule
Friday, March 1
9:00 AM
Dr. Cowen / Introduction
9:05 AM
Dr. Rosenstein / Pathophysiology of skin GVHD
9:20 AM
Dr. Bishop / Ocular manifestations of GVHD
9:35 AM
Dr. Mays / Oral manifestations of GVHD
9:50 AM
Dr. Naik / Gynecologic manifestations of GVHD
10:10 AM
Comis / Adaptive strategies for patients with skin sclerosis
10:25 AM
Dr. Cowen / Management of skin GVHD
10:45 AM
All faculty / Discussion
Event Details
  • Date
    Friday, March 1
  • Time
    9:00 AM - 11:00 AM
  • Location
    Room 103A
  • CME Credits
    2.00
  • Type
    New
Directors/Co-Directors
Speakers